Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke - Takeaways - MDSpire

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke

  • By

  • Wei-Meng Guo

  • Dong-Liang Tian

  • Zhong-Xu Gao

  • Hai-Chao Lv

  • Shuo Sun

  • July 1, 2026

  • 0 min

Share

  • 1

    The study enrolled 175 patients with large artery atherosclerotic stroke to investigate the impact of diabetes duration on inflammatory lipid mediators.

  • 2

    Higher levels of lipoxin A4 and leukotriene B4 were observed in patients with diabetes duration of 5 years or more compared to those with shorter durations.

  • 3

    No significant differences in lipid mediator levels were found between patients with and without type 2 diabetes mellitus.

  • 4

    The study found that diabetes duration positively correlated with levels of lipoxin A4 and leukotriene B4.

  • 5

    Exploratory analyses indicated that lipoxin A4 may serve as a candidate signaling molecule for further investigation in stroke outcomes.

Original Source(s)

Diabetes-duration-related shifts in inflammation-resolving lipid mediator signatures and their association with 3-month functional outcome in large artery atherosclerotic stroke

  • by Wei-Meng Guo, Dong-Liang Tian, Zhong-Xu Gao, Hai-Chao Lv, Shuo Sun

  • July 1, 2026

Related Content

A systematic review on using intervention mapping to guide behavioral interventions for improving stroke patient outcomes

Performance and usability of retrieval-augmented large language models for stroke patient and caregiver support

Case Report: Recurrent cerebral embolism secondary to direct cardiac invasion by lung adenocarcinoma